(PharmaNewsWire.Com, February 03, 2017 ) Publisher's, "Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the...
(PharmaNewsWire.Com, February 03, 2017 ) Publisher's, "Diglyceride Acyltransferase (DGAT) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Diglyceride Acyltransferase (DGAT) Inhibitors. The Publisher's Report...
(PharmaNewsWire.Com, February 03, 2017 ) Publisher's, "Anti-CD30 Antibody-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD30 Antibody. The Publisher's Report covers the product profiles in various stages of development...
(PharmaNewsWire.Com, February 03, 2017 ) Publisher's, "Adenosine A2A Receptor Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Adenosine A2A Receptor Agonists. The Publisher's Report covers the product profiles...
(PharmaNewsWire.Com, February 03, 2017 ) " Congenital Heart Disease-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Congenital Heart Disease.covers the product profiles in various stages of development including Discovery,...
(PharmaNewsWire.Com, February 03, 2017 ) Publisher's, "Fc-Gamma Receptor Antagonist-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fc-Gamma Receptor Antagonist. The Publisher's Report covers the product profiles in various...
(PharmaNewsWire.Com, February 03, 2017 ) Publisher's, "Checkpoint Kinase 2 (Chk2) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Checkpoint Kinase 2 (Chk2) Inhibitors. The Publisher's Report covers the product...
(PharmaNewsWire.Com, February 03, 2017 ) Publisher's, "Cannabinoid Receptor Type 1 (CB1) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Cannabinoid Receptor Type 1 (CB1) Agonists. The Publisher's Report covers...
(PharmaNewsWire.Com, February 03, 2017 ) Publisher's, "Endothelin Receptor A (ETA) Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Endothelin Receptor A (ETA) Antagonists. The Publisher's Report covers the...
(PharmaNewsWire.Com, February 03, 2017 ) Publisher's, "Leptin Receptor (LEP-R) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Leptin Receptor (LEP-R) Agonists. The Publisher's Report covers the product profiles...
(PharmaNewsWire.Com, February 03, 2017 ) According to the report Latin America Antivenom Market, published by Market Data Forecast, the Europe market is projected to reach USD 153.9 million by 2021, at a CAGR of 6.15% from 2016 to 2021.For full report refer to http://www.marketdataforecast.com/market-reports/latin-america-antivenom-market-1584/Anti-venom...
(PharmaNewsWire.Com, February 03, 2017 ) Gastrointestinal stents consist of stents that include trans-hepatic, esophageal, biliary stents, pancreatic and duodenal stents. The stents are used during colorectal cancer, inflammatory bowel disease, GI bleeding, and other diseases. SEMSs are considered...
(PharmaNewsWire.Com, February 03, 2017 ) "N-Cadherin Protein Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the N-Cadherin Protein Antagonists. The Report covers the product profiles in various stages of development...
(PharmaNewsWire.Com, February 03, 2017 ) Publisher's, "mGlu5 Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the mGlu5 Antagonists. The Publisher's Report covers the product profiles in various stages of development...
(PharmaNewsWire.Com, February 03, 2017 ) Publisher's, "Serotonin (5-HT) Receptor Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Serotonin (5-HT) Receptor Agonists. The Publisher's Report covers the product profiles...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: